Tenofovir Disoproxil Fumarate(Tdf) Tablets Suppliers & Bulk Manufacturers

Available Forms: Oral tablets

Available Strengths: 300 mg

Reference Brands: Viread® (EU & US)

Category: Hepatitis

Tenofovir Disoproxil Fumarate(TDF) tablets is available in Oral tablets and strengths such as 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tenofovir Disoproxil Fumarate(TDF) tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Tenofovir Disoproxil Fumarate(TDF) tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Tenofovir Disoproxil Fumarate (TDF) is a potent nucleotide reverse transcriptase inhibitor used to treat chronic Hepatitis B virus (HBV) infection and HIV-1. Available as oral tablets at 300 mg strength, TDF effectively blocks viral replication by inhibiting viral reverse transcriptase enzymes, reducing viral load and preventing disease progression. Marketed under the brand name Viread® by Gilead Sciences, it is approved by the US FDA and EMA. Widely prescribed in both the EU and US, Tenofovir Disoproxil Fumarate is essential for pharma B2B suppliers and healthcare providers managing viral hepatitis and HIV therapies.